Peter K - Search Results

1

Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.

Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K. Stoll P, et al. Among authors: peter k. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1206-12. doi: 10.1161/ATVBAHA.106.138875. Epub 2007 Feb 22. Arterioscler Thromb Vasc Biol. 2007. PMID: 17322097

2

A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity state.

Peter K, Bode C. Peter K, et al. Blood Coagul Fibrinolysis. 1996 Mar;7(2):233-6. doi: 10.1097/00001721-199603000-00031. Blood Coagul Fibrinolysis. 1996. PMID: 8735827

3

Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kübler W, Bode C. Peter K, et al. Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):505-12. doi: 10.1161/01.atv.17.3.505. Arterioscler Thromb Vasc Biol. 1997. PMID: 9102169

4

Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo.

Gries A, Bode C, Peter K, Herr A, Böhrer H, Motsch J, Martin E. Gries A, et al. Among authors: peter k. Circulation. 1998 Apr 21;97(15):1481-7. doi: 10.1161/01.cir.97.15.1481. Circulation. 1998. PMID: 9576429 Clinical Trial.

5

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

Peter K, Schwarz M, Ylänne J, Kohler B, Moser M, Nordt T, Salbach P, Kübler W, Bode C. Peter K, et al. Blood. 1998 Nov 1;92(9):3240-9. Blood. 1998. PMID: 9787160 Free article.

6

The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery.

Gries A, Bode C, Gross S, Peter K, Böhrer H, Martin E. Gries A, et al. Among authors: peter k. Anesth Analg. 1999 Jun;88(6):1213-9. doi: 10.1097/00000539-199906000-00005. Anesth Analg. 1999. PMID: 10357321 Clinical Trial.

7

A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation.

Ruef J, Nordt TK, Peter K, Runge MS, Kübler W, Bode C. Ruef J, et al. Among authors: peter k. Thromb Haemost. 1999 Jul;82(1):109-14. Thromb Haemost. 1999. PMID: 10456463

8

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.

Peter K, Straub A, Kohler B, Volkmann M, Schwarz M, Kübler W, Bode C. Peter K, et al. Am J Cardiol. 1999 Sep 1;84(5):519-24. doi: 10.1016/s0002-9149(99)00370-7. Am J Cardiol. 1999. PMID: 10482148

9

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).

Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kübler W, Bode C. Peter K, et al. Circulation. 1999 Oct 5;100(14):1533-9. doi: 10.1161/01.cir.100.14.1533. Circulation. 1999. PMID: 10510057

10

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.

Moser M, Nordt T, Peter K, Ruef J, Kohler B, Schmittner M, Smalling R, Kübler W, Bode C. Moser M, et al. Among authors: peter k. Circulation. 1999 Nov 2;100(18):1858-64. doi: 10.1161/01.cir.100.18.1858. Circulation. 1999. PMID: 10545429 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

954 results

Search Page

Filters